Human Imatinib Mesylate-Resistant Leukemia Cell Line
Invented at Virginia Commonwealth University
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 154032 |
| Parental Line | BV173 |
| Host | Human |
| Disease Keywords | Cancer; Acute Lymphoblastic Leukemia (Ph+ ALL); Chronic Myelogenous Leukemia (CML) |
| Relevance | The human ALL cell line, named BV173, was altered to be imatinib resistant and contains the most frequently observed mutation (E255K) responsible for drug resistance in patients. |
| Research Area | Cancer |
References: 2 entries
Cormack et al. 1992. J Mol Biol. 228(4):1078-90. PMID: 1474579.
Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro.
Europe PMC ID: 1474579
Add a reference
References: 2 entries
Cormack et al. 1992. J Mol Biol. 228(4):1078-90. PMID: 1474579.
Structural requirements for the processing of Escherichia coli 5 S ribosomal RNA by RNase E in vitro.
Add a reference
